Cybin Inc. (NEO:CYBN) (NYSE: CYBN) provided a corporate update outlining access to capital and upcoming clinical milestones. Cybin stated that it had a potential funding of C$70 million funding through a combination of the previously announced common share purchase agreement and current “at-the-market” equity program. Cybin announced at the end …